MRC1 and colorectal carcinoma: However, since a limited sample number of classical CRC cell lines was used, off-target effects of the genetic modifications are possible and, most importantly, the MMR-proficient cell lines are still hypermutated, since the reintroduction of a defective MMR gene does not revert mutations already present in the cells; thus, a direct comparison to our data is not valid.